Erratum to “Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 study”

by | Jun 27, 2024 | Publications | 0 comments

Cancer. 2024 Jun 27. doi: 10.1002/cncr.35464. Online ahead of print.

NO ABSTRACT

PMID:38935525 | DOI:10.1002/cncr.35464

Submit a Comment